Bionow | News

Tech Pioneer Awarded to Manchester Entrepreneur

Jul 5th 2024

Dr. Farid Khan, CEO of PharmaKure was awarded Asian Tech Pioneer in his work in Biotech.

Blueberry Therapeutics Meets Primary and Secondary Endpoints in Phase 2b Trial i...

Nov 22nd 2023

Blueberry Therapeutics Limited (“Blueberry” or “the Company”), a pharmaceutical company focused on developing innovative, topical nanomedicines to treat dermatological conditions, an...

Sight-saving MedTech sleep mask could save the NHS multimillions

Oct 28th 2022

MedTech company PolyPhotonix has had its innovative diabetes sleep mask adopted in the NHS for the first time.

Onyx Health Joins Forces with Rare Disease Specialists Actigen

Apr 14th 2022

The Newcastle based agency Onyx Health will be working with Actigen to raise awareness of their innovative clinical trial work in rare diseases and the need to develop new treatment solution...

£1.3M to develop new inhaled drug delivery platforms to treat viral and bacteri...

Mar 8th 2022

The University of Liverpool in partnership with the Liverpool School of Tropical Medicine have joined forces on a £1.3million research project to develop new inhaled drug delivery platforms...

Liverpool recruits first UK patient for personalised ‘therapeutic cancer vacci...

Jul 1st 2021

Researchers in Liverpool have begun recruiting patients to a ‘first-in-human’ clinical trial of personalised ‘vaccines’ that aim to reduce the risk of head and neck cancers – which...

Aptamer Group and PinotBio collaborate to develop new therapeutic drug conjugate...

Jun 2nd 2021

Aptamer Group Limited, the developer of Optimer™ Therapeutics, and PinotBio (Gyeonggi-do, Korea), a clinical-stage oncology-focused biotechnology company, today announces that they have en...

UK Innovators Target Nanoparticles at Inoperable Cancers

Dec 21st 2020

Active Needle Technology, Xerion Healthcare and Medicines Discovery Catapult win funding to begin ground-breaking project

Innovative COVID-19 drug testing platform launched

Jul 9th 2020

The University of Liverpool, Liverpool School of Tropical Medicine and Southampton Clinical Trials Unit have announced the launch of an innovative COVID-19 drug testing platform, AGILE.

From data to drugs - a brief introduction to AI in drug discovery

Oct 16th 2019

The road to an approved drug is well known to be an arduous journey. The use of artificial intelligence (AI) in the drug discovery process is receiving a lot of attention.

Gender medicine – deriving novelty from treating women?

Aug 29th 2019

When you hear the term “gender medicine”, what comes to mind? For many people, the term is associated with reproductive health issues, such as pregnancy, genitourinary medicine, or endoc...

CLYZ Labs announces commencement of clinical trial and seed funding from Catapul...

Aug 22nd 2018

CLYZ Labs, an award-winning early-stage cancer diagnostics company, today announced that the first clinical trial involving its innovative Cancertain™ test has secured all regulatory appro...

News